Improved Glycaemic Control and Nephroprotective Effects of Empagliflozin and Paricalcitol Co-Therapy in Mice with Type 2 Diabetes Mellitus.
Mujalli A, Farrash WF, Obaid AA, Khan AA, Almaimani RA, Idris S, Elzubier ME, Khidir EBA, Aslam A, Minshawi F, Alobaidy MA, Alharbi AB, Almasmoum HA, Ghaith M, Alqethami K, Refaat B.
Mujalli A, et al. Among authors: farrash wf.
Int J Mol Sci. 2023 Dec 12;24(24):17380. doi: 10.3390/ijms242417380.
Int J Mol Sci. 2023.
PMID: 38139208
Free PMC article.